Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 336 of 1,261
  1. US 11033621

    Combination therapies targeting tumor-associated stroma or tumor cells

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted
  2. US 11033620

    Combination therapies targeting tumor-associated stroma or tumor cells and microtubules

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted
  3. US 11033615

    Zika virus vaccine and methods of production

    The Government of the United States, As Represented by the Secretary of the Army Fort Detrick, Maryland · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted
  4. US 11034740

    Brachyury deletion mutants, non-yeast vectors encoding Brachyury deletion mutants, and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted
  5. US 11033631

    Methods of treating CYP2D6 alternative metabolizers

    Nektar Therapeutics · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted
  6. US 11033601

    Selective inhibition of V1b for treating fatty liver

    The Regents of the University of Colorado, a Body Corporate · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted
  7. US 11033588

    Compositions for treating inflammation and uses thereof

    The Regents of the University of California · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted
  8. US 11033584

    Targeted replacement of endogenous T cell receptors

    The Regents of the University of California · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted
  9. US 11033570

    Modulation of Lnc05 expression

    Ionis Pharmaceuticals, Inc. · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted
  10. US 11033560

    Triazole bisphosphonate geranylgeranyl diphosphate synthase inhibitors

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted
  11. US 11033554

    Use of dopamine and serotonin receptor antagonists for treatment in a subject with retinal degeneration

    United States Government as represented by the Department of Veterans Affairs · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted
  12. US 11033556

    Bicyclic sulfonamides

    Aligos Therapeutics, Inc. · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted
  13. US 11033550

    Medicament

    Takeda Pharmaceutical Company Limited · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted
  14. US 11033541

    Epimorphic regeneration and related hydrogel delivery systems

    Northwestern University · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted
  15. US 11033551

    Methods of treating uterine fibroids

    Takeda Pharmaceutical Company Limited · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted
  16. US 11033533

    (2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid

    Theravance Biopharma R&D IP, LLC · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted
  17. US 11033537

    LPT-723 and immune checkpoint inhibitor combinations and methods of treatment

    Biomed Valley Discoveries, Inc. · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted
  18. US 11033505

    Oral complex preparation comprising fat-soluble drug and solid preparation coated with oil-proof material

    United Science R&D Center · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted
  19. US 11033496

    Nanoparticles for delivery of chemopreventive agents

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted
  20. US 11033516

    Combination therapies with disulfiram

    Spring Discovery, Inc. · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted
  21. US 11033467

    Zirconia composition, partially sintered material and sintered material and methods for production thereof, and laminate

    KURARAY NORITAKE DENTAL INC. · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted
  22. US 11033495

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted
  23. US 11033494

    Apparatuses containing an emulsion and methods of manufacture

    Recursion Pharmaceuticals, Inc. · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted
  24. US 11033491

    Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof

    Vyne Therapeutics Inc. · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.